SI
SI
discoversearch

We've detected that you're using an ad content blocking browser plug-in or feature. Ads provide a critical source of revenue to the continued operation of Silicon Investor.  We ask that you disable ad blocking while on Silicon Investor in the best interests of our community.  If you are not using an ad blocker but are still receiving this message, make sure your browser's tracking protection is set to the 'standard' level.
Biotech / Medical : Sepracor-Looks very promising

 Public ReplyPrvt ReplyMark as Last ReadFilePrevious 10Next 10PreviousNext  
From: Icebrg12/7/2006 3:12:02 PM
   of 10280
 
Lunesta Chief Marketer Makes a Move
December 07, 2006

By Jim Edwards

NEW YORK -- Timothy Healey, the chief marketer on Sepracor’s Lunesta sleep drug and a 2006 Brandweek Marketer of the Year, has left the company to become svp of commercial operations at Advanced Magnetics in Cambridge, Mass.

His last day at Sepracor was last week.

Advanced Magnetics develops therapeutic iron compounds to treat anemia, as well as new agents that aid MRI scans.

At Marlborough, Mass.-based Sepracor, Healey oversaw the launch of Lunesta, which went on to become the No. 2 sleep drug in the U.S. after Sanofi-Aventis’ Ambien. The drug has made over $600 million in sales since its launch and the Lunesta ad budget has topped $200 million annually, the largest single drug-brand budget in the country.

Sources said no decision had been made regarding his replacement, although there is one obvious internal possibility: Jay Popli, Sepracor’s Lunesta’s marketing director, who was named with Healey as a Brandweek Marketer of Year in October.

“Tim is the first of several key hires in our effort to successfully launch ferumoxytol,” Advanced Magnetics’ iron replacement drug for kidney disease patients, said Brian J.G. Pereira, president and CEO of Advanced Magnetics, in a statement.

brandweek.com
Report TOU ViolationShare This Post
 Public ReplyPrvt ReplyMark as Last ReadFilePrevious 10Next 10PreviousNext